NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1424-1430

  Inoue, Hirotaka ^a   Arai, Ikumi ^a   Shibata, Shigenobu ^a,b   Watanabe, Shigenori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Waseda University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DOPAMINE; DRUG DERIVATIVE; ENZYME INHIBITOR; METHAMPHETAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; METABOLISM; RAT; WISTAR RAT; ADOLESCENT; ANIMAL TISSUE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG SENSITIZATION; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARGININE; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; LOCOMOTION; MALE; METHAMPHETAMINE; NG-NITROARGININE METHYL ESTER; RATS; RATS, WISTAR;

EID: 0030302498     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. ABEKAWA, T., OHMORI, T. AND KOYAMA, T.: Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine. Brain Res. 666: 147-150, 1994.
2. G-nitro-L-arginine methyl ester. Life Sci. 52: 245-249, 1993.
3. ANGRIST, B.: Psychoses induced by central nervous system stimulant and related drugs. In Stimulants: Neurochemical, Behavioral, and Clinical Perspectives, ed. by I. Creese, pp. 1-30, Raven Press, New York, 1983.
4. BABEY, A. M., KOLESNIKOV, Y., CHENG, J., INTURRISI, C. E., TRIFILLETTI, R. R. AND PASTERNAK, G. W.: Nitric oxide and opioid tolerance. Neuropharmacology 33: 1463-1470, 1994.
5. BANNERMAN, D. M., CHAPMAN, P. F., KELLY, P. A. T., BUTCHER, S. P. AND MORRIS, R. G. M.: Inhibition of nitric oxide synthase does not prevent the induction of long-term potentiation in vivo. J. Neurosci. 14: 7415-7425, 1994.
6. BREDT, D. S. AND SYNDER, S. H.: Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum, Proc. Natl. Acad. Sci. USA 86: 9030-9033, 1989.
7. BREDT, D. S. AND SYNDER, S. H.: Nitric oxide, a novel neuronal messenger. Neuron 8: 3-11, 1992.
8. CALABRESI, P., ROBERTO, M., MERCURI, N. B. AND BERNARDI, G.: Coactivation of D1 and D2 dopamine receptors is required for long-tern synaptic depression in the striatum. Neurosci. Lett. 142: 95-99, 1992a.
9. CALABRESI, P., ROBERTO, M., PISANI, A., MERCURI, N. B. AND BERNARDI, G.: Longterm synaptic depression in the striatum: Physiological and pharmacological characterization. J. Neurosci. 12: 4224-4233, 1992b.
10. CARLSSON, M. AND CARLSSON, A.: Interactions between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13: 272-276, 1990.
11. CASTANEDA, E., BECKER, J. B. AND ROBINSON, T. E.: The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci. 42: 2447-2456, 1988.
12. COCAN, E. J., SAYWOOD, W. AND COLLINGRIDGE, G. L.: MK-801 blocks NMDA receptor-mediated synaptic transmission and long-term potentiation in rat hippocampal slices. Neurosci. Lett. 80: 111-114, 1987.
13. DANIEL, H., HEMART, N., JAILLARD, D. AND CREPEL, F.: Long-term depression requires nitric oxide and guanosine 3′:5′ cyclic monophosphate production in rat cerebellar Purkinje cells. Eur. J. Neurosci. 5: 1079-1082, 1993.
14. GNEGY, M. E., HEWLETT, G. H. K., YEE, S. L. AND WELSH, M. J.: Alterations in calmodulin content and localization in areas of rat brain after repeated intermittent amphetamine. Brain Res. 562: 6-12, 1991.
15. HAMAMURA, T., AKIYAMA, K., AKIMOTO, K., KASHIHARA, K., OKUMURA, K., UJIKE, H. AND OTUKI, S.: Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 546: 40-46, 1991.
16. 3]-dopamine from striatal slices. Neuroreport 3: 409-412, 1992.
17. HALEY, J. E., WILCOX, G. L. AND CHAPMAN, P. F.: The role of nitric oxide in hippocampal long-term potentiation. Neuron 8: 211-216, 1992.
18. HERNANDEZ, F., ALEXANDER, S. P. H. AND DAVID, A. K.: Folskolin and 3-isobutyl-1-methylxanthin increase basal and sodium nitroprusside-elevated cyclic GMP levels in adult guinea-pig cerebellar slices. J. Neurochem. 62: 2212-2218, 1994.
19. HIRABAYASHI, M. AND ALAM, M. R.: Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice. Pharmacol. Biochem. Behav. 15: 925-932, 1981.
20. IGA, Y., YOSHIOKA, M., TOGASHI, H. AND SAITO, H.: Inhibitory action of N omeganitro-L-arginine methyl ester on in vivo long-term potentiation in the rat dentate gyrus. Eur. J. Pharmacol. 238: 395-398, 1993.
21. IZUMI, Y., DAVID, B. C. AND CHARLES, F. Z.: Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science 257: 1273-1276, 1992.
22. KARLAR, R., CALDER, L. D. AND TURKAINS, S. A.: DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552: 295-300, 1991.
23. KARLAR, R., CHAUDHRY, I. A., CALDER, L. D. AND TURKANIS, S. A.: Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537: 76-82, 1990.
24. KOLTA, M. G., SHEREVE, P., D. E. SOUZA, V. AND URETSKY, N. J.: Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24: 823-839, 1985.
25. KUCZENSKI, R. AND SEGAL, D.: Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9: 2051-2065, 1989.
26. LORRAIN, D. S. AND HULL, E. M.: Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport 5: 87-89, 1993.
27. MIZUTANI, A., SAITO, H. AND ABE, K.: Involvement of nitric oxide in long-term potentiation in the dentate gyrus in vivo. Brain Res. 605: 309-311. 1993.
28. NICOLAS, J. T. AND PETER, J. R.: NMDA receptor-mediated stimulation of rat cerebellar nitric oxide formation is modulated by cyclic AMP. Eur. J. Pharmacol. 266: 63-66. 1994.
29. OKADA, D.: Two pathways of cyclic GMP production through glutamate recep-tor-mediated nitric oxide synthesis. J. Neurochem. 59: 1203-1210, 1992.
30. OCHI, M., INOUE, H., SHIBATA, S. AND WATANABE, S.: Long-term enhancement of dopamine release by high frequency tetanic stimulation via a N-methyl-D-aspartate-receptor-mediated pathway in rat striatum. Neuroscience 66: 29-36, 1994.
31. PATRICK, S. L., THOMPSON, T. L., WALKER, J. M. AND PATRICK, R. L.: Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Res. 538: 343-346, 1991.
32. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
33. POPOV, N. AND MATTHIES, H.: Influence of dopamine receptor agonists and antagonists on calmodulin translocation in different brain regions. Eur. J. Pharmacol. 172: 205-210, 1989.
34. PUDIAK, C. M. AND BOZARTH, M. A.: L-NAME and MK-801 attenuates sensitization to the locomotor stimulated effect of cocaine. Life Sci. 53: 1517-1524, 1993.
35. ROBINSON, T. E., JUHSON, P. A., BENNETT, J. A. AND BENTGEN, K. M.: Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: A microdialysis study in freely moving rats. Brain Res. 462: 211-222, 1988.
36. ROBINSON, T. E. AND BECKER, J. B.: Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharmacol. 85: 253-254, 1982.
37. ROBERTS-LEWIS, J. M., WELSH, M. J. AND GNEGY, M.: Chronic amphetamine treatment increases striatal calmodulin in rats. Brain Res. 384: 383-386, 1986.
38. ROY, S. N., BATTACHAHYYA, A. K., PRADHAN, S. AND PRADHAN, S. N.: Behavioral and neurochemical effects of repeated administration of cocaine in rats. Neuropharmacology 17: 559. 1978.
39. 3]dopamine uptake. Brain Res. 641: 83-91. 1994.
40. SALTER, M., DUFFY, C., GABTHWAITE, J. AND STRIJBOS, P. J. L. M.: Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of Nω-nitro-L arginine (L-NA) and its methyl ester (L-NAME). Neuropharmacol. 34: 639-649, 1995.
41. SEGAL, D. S. AND KUCZENSKI, R.: In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 571: 330-337, 1992.
42. SEGAL, D. S. AND SCHUCKIT, M. A.: Animal models of stimulant induced psychosis. In Stimulants: Neurochemical, Behavioral, and Clinical Perspectives, ed. by I. Creese, pp. 131-168, Raven Press, New York, 1983.
43. SHIBATA, S., MINAMOTO, Y., ONO, M. AND SHIGENORI, W.: Age-related impairment of food-anticipatory locomotor activity rhythm in rats. Physiol. Behav. 55: 875-878, 1994.
44. STEWART, J., DESCHAMPS, S. E. AND AMIR, S.: Inhibition of nitric oxide synthase dose not block the development of sensitization to the behavioral activating effects of amphetamine. Brain Res. 641: 141-144, 1994.
45. SUGAYA, K. AND MICINNY, M.: Nitric oxide gene expression in cholinergic neurons in the rat brain examined by combined immunocytochemistry and in situ hybridization histochemistry. Mol. Brain Res. 23: 111-125, 1994.
46. SWARTZWELDER, H. S., FERRARI, C., ANDERSON, W. W. AND WILSON, W. A.: The drug MK-801 attenuates the development, but not the expression, of long-term potentiation and stimulus train-induced bursting in hippocampal slices. Neuropharmacology 28: 441-445, 1989.
47. ω-nitro-L-arginine in rats. Br. J. Pharmacol. 111: 394-396, 1994.
48. TILSON, H. A. AND RECH, R. H.: Conditioned drug effects and absence of tolerance to d-amphetamine induced locomotor activity. Biochem. Behav. 1: 149-154. 1973.
49. UJIKE, H., AKIYAMA, K. AND OTUKI, S.: D-2 but not D-1 dopamine agonists augmented behavioral response in rate after subchronic treatment with methamphetamine or cocaine. Psychopharmacology 102: 459-464, 1990.
50. UJIKE, H., ONOUE, T., AKIYAMA, K., HAMAMURA, T. AND OTUKI, S.: Effects of selective D-1 and D-2 antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology 98: 89-92, 1989.
51. VINCENT, S. R. AND KIMURA, H.: Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46: 755-784, 1992.
52. WOLF, M. E. AND KHANSA, M. R.: Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562: 164-168, 1991.
53. WOLF, M. E., WHITE, F. J., NASSAR, R., BROODBRSON, R. J. AND KHANSA, M. R.: Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264: 249-255, 1993.
54. WOLF, M. E., WHITE, F. J. AND Hu, X.-T.: MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci. 14: 1735-1745, 1994.
55. ZHU, X. Z. AND Luo, L. G.: Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem. 59: 932-935, 1992.